Pfizer Inc (PFE)
38.38
+0.35 +0.92%
NYSE
Dec 6, 13:34
Delayed 2m
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 53.04B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 2.86 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 16.22B |
| Profitability | |
| Gross Profit Margin (Quarterly) | 79.48% |
| Profit Margin (Quarterly) | 60.57% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 3.75% |
| Price and Valuation | |
| Market Cap | 212.40B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 4.158 |
| PE Ratio (TTM) | 13.42 |
| Price to Book Value | 3.263 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | 0.8089 |
| Free Cash Flow (Quarterly) | 3.848B |
| Return on Equity (TTM) | Upgrade |
View All PFE News
News
-
WireHeadlineTime (ET)
-
MT Newswires12/06 13:22
-
Yahoo12/06 09:27
-
MT Newswires12/06 09:15
-
Yahoo12/06 08:32
-
Yahoo12/05 20:50
-
Yahoo12/05 09:58
-
MT Newswires12/05 09:17
-
MT Newswires12/05 08:22
-
Yahoo12/04 17:52
-
Yahoo12/04 10:00
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 01/29/2020 10:00 EST | Misc | Pfizer Inc Fourth Quarter Earnings Conference Call in 2019 |
| 01/29/2020 | Earnings | Pfizer Inc Fourth Quarter Earnings in 2019 Release |
| 11/07/2019 | Dividends | Amount: 0.36, Declared Date: Sep 24 2019, Pay Date: Dec 02 2019 |
| 10/29/2019 10:00 EDT | Misc | Pfizer Inc Third Quarter Earnings Conference Call for 2019 |
| 10/29/2019 | Earnings | Pfizer Inc Third Quarter Earnings for 2019 Release |
| 08/01/2019 | Dividends | Amount: 0.36, Declared Date: Jun 27 2019, Pay Date: Sep 03 2019 |
| 07/30/2019 10:00 EDT | Misc | Pfizer Inc Second Quarter Earnings Conference Call in 2019 |
| 07/30/2019 | Earnings | Pfizer Inc Second Quarter Earnings in 2019 Release |
| 05/09/2019 | Dividends | Amount: 0.36, Declared Date: Apr 25 2019, Pay Date: Jun 07 2019 |
| 04/30/2019 10:00 EDT | Misc | Pfizer Inc First Quarter Earnings Conference Call in 2019 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: http://www.pfizer.com
- Investor Relations URL: http://www.pfizer.com/investors
- HQ State/Province: New York
- Sector: Healthcare
- Industry: Drug Manufacturers - General
- Equity Style: Large Cap/Value
- Next Earnings Release: Jan. 29, 2020
- Last Earnings Release: Oct. 29, 2019
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Nov. 07, 2019
- Description: Pfizer is one of the world's largest pharmaceutical firms, with annual sales over $50 billion. Pfizer also spends a leading amount on research and development, close to $8 billion annually. While Pfizer historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, neuroscience drug Lyrica, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor, representing over a fifth of total company sales.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 38.38 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| XLV | Health Care Select Sector SPDR® ETF | 5.72% |
| VGHCX | Vanguard Health Care Inv | 4.64% |
| RWMAX | American Funds Washington Mutual R1 | 1.63% |
| VTV | Vanguard Value ETF | 1.61% |
| RIDHX | American Funds Income Fund of Amer R5E | 1.38% |
| VFINX | Vanguard 500 Index Investor | 0.84% |
| VOO | Vanguard S&P 500 ETF | 0.84% |
| VINIX | Vanguard Institutional Index I | 0.84% |
| SPY | SPDR® S&P 500 ETF Trust | 0.81% |
| IVV | iShares Core S&P 500 ETF | 0.81% |
| VSTSX | Vanguard Total Stock Mkt Idx Instl Sel | 0.70% |
| VTI | Vanguard Total Stock Market ETF | 0.70% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- PFE Tweets Stocktwits
Advertisement
